Pfizer to sell stake in GSK consumer health joint venture after spinoff | HealthCare Middle East & Africa Magazine
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners - Simply Wall St News
GSK-HUL deal: HUL shares gain after Horlicks deal; should you buy or sell stock? What brokerages say - Market News | The Financial Express
GSK: Glaxo SmithKline Share Price Target 2023, 2025, 2027, 2030 to 2050 - Sharedhan
Is GSK a Strong Buy Right Now? | The Motley Fool
GlaxoSmithKline to leave landmark global HQ after split-up as consumer health business plots £120M new home | Fierce Pharma
GSK Raises Almost £1 Billion by Selling Another Haleon Stake - Bloomberg
Glaxo plots £8bn move to buy back Beechams stake
GSK to sell 2.9% stake in former consumer healthcare business Haleon | Reuters
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK - MarketWatch
GSK bets on cough drug with $2bn deal for Canadian biotech
GSK (GSK) Declines More Than Market: Some Information for Investors
GlaxoSmithKline reportedly looking to sell select antibiotic brands - PMLiVE
FTSE 100: GSK Reaches Settlement in Zantac Lawsuit | Markets Insider
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BWRRND7NK5ORFONQ4YXBCQPDTU.jpg "GSK raises $1.24 bln from latest Haleon stake sale | Reuters")
GSK raises $1.24 bln from latest Haleon stake sale | Reuters
GSK To Sell Poznań Manufacturing Site To Delpharm | Contract Pharma
GSK agrees £9bn deal for consumer healthcare stake – and may sell Horlicks to buy it
GSK Shares Gain on Analyst Upgrade, Price Target Boost - TipRanks.com
GSK slapped with 'sell' rating over long-term risks | LSE:GSK, NYSE:GSK
GSK (GSK) Stock Price, News & Info | The Motley Fool
The trading activity of the stock GSK between the 26500 − 28500'th... | Download Scientific Diagram
